Meta-analysis of 82 studies comparing 12-month visual acuity change results in routine clinical practices of intravitreal therapy for diabetic maculaedema (DME) to the change in RCTs by pooling data published in the last decade on treated eyes of treatment effect from OS.
A dataframe with 83 rows and 24 columns. Each row represents study results, the columns are:
Used Medication
Author and year.
Study type/Design
Number of tested eyes.
Mean Change in Visual Acuity after 12-Months. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
Standard Error of the Treatment Effect
Lower 95prc CI for TE
Upper 95prc CI for TE
Number of Patients in Study at Baseline
The mean age of patients per study
The standard deviation of age of patients per study
The standard error of age of patients per study
Mean Visual Acuity at Baseline. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
The standard deviation of Visual Acuity at Baseline. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
The standard error of Visual Acuity at Baseline. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
Mean Visual Acuity after 12 months. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
The standard deviation of Visual Acuity after 12 months. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
The standard error of Visual Acuity after 12 months. Where Visual Acuity is measured in VAR (Visual Acuity Rating) score
Mean Central Subfield Thickness at Baseline
The standard deviation of Central Subfield Thickness at Baseline
The standard error of Central Subfield Thickness at Baseline
Mean Central Subfield Thickness after 12 months
The standard deviation of Central Subfield Thickness after 12 months
The standard error of Central Subfield Thickness after 12 months